You will now be redirected to the GD3 website
Genesis Drug Discovery & Development is a proud member of Genesis Drug Discovery & Development (GD3), a fully integrated CRO providing services to support drug discovery programs of our clients from target discovery through IND filing and managing Phase I-III clinical trials.
Learn more about GD3Disease Modeling
Noninvasive In vivo Bioluminescence or Fluorescence Imaging
In vivo bioluminescence and fluorescence imaging provide crucial noninvasive insight into the biological processes, disease progression and therapeutic response in live animals without requiring surgical procedures or tissue extraction. This powerful tool can accelerate the development of new therapies by providing researchers with a safe, efficient, and informative way of observing drug candidates' effects on living organisms.
- Located within the vivarium to provide real-time noninvasive in vivo imaging technology to monitor orthotopic tumor growth and metastases
- Customizable luciferase-tagged tumor cell line generation by request
Learn more about